Botanical species · safety record

Ajuga iva

The EFSA Compendium of Botanicals holds 3 constituent measurements and 1 adverse-effect record for Ajuga iva. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ajuga iva (L.) Schreb.

3Constituent measurements

1Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Ajuga pseudoiva Labill. & Castagne ex DC.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Clerodane-type diterpenes	Aerial part of plants	—	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Clerodane-type diterpenes	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Clerodane-type diterpenes	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Live plants	Solvent extraction	Rat (as animal)	Short-term toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Camps, Francisco., Coll, Jose., Dargallo, Oriol. Neo-clerodane diterpenoids from Ajuga pseudoiva.. Phytochemistry (elsevier), 1984, vol. 23, no. 2, p. 387-9.
El Hilaly, J., Lyoussi, B. Hypoglycaemic effect of the lyophilised aqueous extract of Ajuga iva in normal and streptozotocin diabetic rats . Journal of ethnopharmacology, 2002, vol. 80, no. 2-3, p. 109-113.
Bondi, ML., Al-Hillo, MRY., Lamara, K., Ladjel, S., Bruno, M., Piozzi, F., Simmonds, MSJ. Occurrence of the antifeedant 14,15-dihydroajugapitin in the aerial parts of Ajuga iva from Algeria . Biochemical systematics and ecology, 2000, vol. 28, no. 10, p. 1023-1025. DOI
Jannet, H. Ben., Harzallah-Skhiri, F., Mighri, Z., Simmonds, M. S. J., Blaney, W. M. Responses of Spodoptera littoralis larvae to Tunisian plant extracts and to neo-clerodane diterpenoids isolated from Ajuga pseudoiva leaves.. Fitoterapia, 2000, vol. 71, no. 2, p. 105-112.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature